Anchiano Therapeutics is a biopharmaceutical company dedicated to the discovery, development, and commercialization of novel targeted therapies to treat cancer.
Employees: 11-50
Total raised: $23M
Founded date: 2004
Investors 1
| Date | Name | Website |
| 26.10.2023 | Arc Ventur... | arc-vc.com |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 12.04.2018 | - | $23M | - |
Mentions in press and media 4
| Date | Title | Description | Source |
| 10.03.2021 | ANCHIANO THERAPEUTICS LTD. : Other Events (form 8-K) | Item 8.01. Other Events. Supplemental Disclosures As previously disclosed, on December 14, 2020, An... | marketscre... |
| 02.02.2021 | Chemomab Announces First Patient Enrolled in Phase IIa Study... | TEL AVIV, Israel, Feb. 2, 2021 /PRNewswire/ -- Chemomab Ltd., a clinical-stage biotech company foc... | prnewswire... |
| 05.01.2021 | Chemomab Announces Positive Phase Ib Results of its SPARK st... | TEL AVIV, Israel, Jan. 5, 2021 /PRNewswire/ -- Chemomab Ltd., a clinical-stage biotech company foc... | prnewswire... |
| 08.01.2019 | Lilly to display drug pricing info on website; Catalen... | → Since the bipartisan bill compelling pharmaceutical companies to display drug prices as... | endpts.com... |